Notable healthcare headlines for the week: AstraZeneca, CVS Health and Moderna in focus (XLV:NYSEARCA)

Notable healthcare headlines for the week: AstraZeneca, CVS Health and Moderna in focus (XLV:NYSEARCA)

Wall Street healthcare weekly recap: XLV gains, top S&P 500 winners/losers, and key earnings & deal news on AstraZeneca, CVS, Moderna & Lilly—read now.

Healthcare stocks head into Presidents Day break after Dexcom, Moderna lift XLV

The Health Care Select Sector SPDR Fund (XLV) rose 1.1% to $157.67 Friday, led by Dexcom’s 7.6% jump and Moderna’s 5.3% gain after earnings. Dexcom beat Q4 estimates and reiterated its 2026 outlook, while Moderna forecast up to 10% revenue growth, citing overseas markets. Broader markets saw tech lag as inflation data cooled. U.S. exchanges close Monday for Presidents Day. The post Healthcare stocks head into Presidents Day break after Dexcom, M…